The mRNA Patent and Competitive Landscape: Pioneers, Litigation Outlook and Big Pharma’s Next Moves (Part III)

May 10, 2021

The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)

May 2, 2021

The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I

April 12, 2021

IP Assignment Considerations for Emerging Companies

March 26, 2021

Dana-Farber Launches New Fund to Support Oncology Startups

January 29, 2021

Hyundai Buys Majority of Boston Dynamics from SoftBank in $1.1B deal

December 14, 2020

Emerging Companies: Framework for Leveraging Your IP & Tech

December 4, 2020

COVID-19 Vaccine Leader Moderna “Not Aware of Any Significant Intellectual Property Impediments” in Development of its Vaccine Despite Mixed Results at PTAB

November 16, 2020

World Economic Forum Releases Top 10 Emerging Technologies of 2020

November 10, 2020

Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?

November 9, 2020